Patients with clinical stage IV of lung cancer accounted for 65.0% in the debilitating group, higher than 54.1% in the non-debilitating group, while the proportion of clinical stages (phases I, II, III) in the weak group was lower than in the non-debilitating group, and the difference was statistically significant (P-0.012).
正在翻译中..